Literature DB >> 23990035

Advanced disease, diuretic use, and marital status predict hospital admissions in an ambulatory cirrhosis cohort.

Kara B Johnson1, Emily J Campbell, Heng Chi, Hui Zheng, Lindsay Y King, Ying Wu, Andrew Delemos, Abu Hurairah, Kathleen Corey, James M Richter, Raymond T Chung.   

Abstract

BACKGROUND AND AIMS: Hospital admissions in cirrhotic patients are a source of significant health care expenditure. Most studies to date have focused on readmissions in patients with decompensated cirrhosis. We sought to describe predictors of hospital admissions in an ambulatory cirrhosis cohort consisting of both compensated and decompensated patients to identify patients who could benefit from intensified outpatient chronic disease management.
METHODS: We performed a retrospective cohort study of 395 cirrhotic patients followed at an academic medical center liver clinic. Inclusion criteria were documented cirrhosis and longitudinal care at our center during 2006-2008. Patients were followed until December 2011, death, or liver transplantation. The primary outcomes were non-elective cirrhosis-related hospital admissions within 1 year and time to admission. The secondary outcome was 2-year cirrhosis-related mortality. The study was approved by the Partners Human Research Committee (protocol 2012P001912).
RESULTS: Seventy-eight patients (19.7 %) had at least one cirrhosis-related hospital admission within 1 year. The following were significant predictors in the multivariable model: model for end-stage liver disease score ≥15 [OR 2.22, 95 % CI (1.21-4.07), p = 0.01], diagnosis of hepatocellular carcinoma [3.64 (1.42-9.35), 0.007], diuretic use [2.27 (1.23-4.17), 0.008], at least one cirrhosis-related admission during the baseline year [2.17 (1.21-3.89), 0.01], and being unmarried [1.92 (1.10-3.35), 0.02].
CONCLUSIONS: Advanced disease, diuretic use, and marital status were associated with cirrhosis-related hospital admissions in patients followed at an academic medical center liver clinic. Our findings suggest that patients with inadequately or overzealously treated ascites, as well as those with limited social supports, could benefit from intensified outpatient management.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23990035      PMCID: PMC3947175          DOI: 10.1007/s10620-013-2832-5

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  14 in total

1.  Burden of liver disease in the United States: summary of a workshop.

Authors:  W Ray Kim; Robert S Brown; Norah A Terrault; Hashem El-Serag
Journal:  Hepatology       Date:  2002-07       Impact factor: 17.425

2.  Incidence and predictors of 30-day readmission among patients hospitalized for advanced liver disease.

Authors:  Kenneth Berman; Sweta Tandra; Kate Forssell; Raj Vuppalanchi; Raj Vuppalanch; James R Burton; James Nguyen; Devonne Mullis; Paul Kwo; Naga Chalasani
Journal:  Clin Gastroenterol Hepatol       Date:  2010-11-17       Impact factor: 11.382

3.  Management of adult patients with ascites due to cirrhosis: an update.

Authors:  Bruce A Runyon
Journal:  Hepatology       Date:  2009-06       Impact factor: 17.425

4.  The effect of marital status on the presentation and outcomes of elderly male veterans hospitalized for pneumonia.

Authors:  Mark L Metersky; Michael J Fine; Eric M Mortensen
Journal:  Chest       Date:  2012-10       Impact factor: 9.410

5.  Medication-related problems occurring in people with diabetes during an admission to an adult teaching hospital: a retrospective cohort study.

Authors:  Kate Claydon-Platt; Elizabeth Manias; Trisha Dunning
Journal:  Diabetes Res Clin Pract       Date:  2012-04-26       Impact factor: 5.602

Review 6.  The model for end-stage liver disease (MELD).

Authors:  Patrick S Kamath; W Ray Kim
Journal:  Hepatology       Date:  2007-03       Impact factor: 17.425

7.  Is obesity a risk factor for cirrhosis-related death or hospitalization? A population-based cohort study.

Authors:  George N Ioannou; Noel S Weiss; Kris V Kowdley; Jason A Dominitz
Journal:  Gastroenterology       Date:  2003-10       Impact factor: 22.682

8.  Underestimation of liver-related mortality in the United States.

Authors:  Sumeet K Asrani; Joseph J Larson; Barbara Yawn; Terry M Therneau; W Ray Kim
Journal:  Gastroenterology       Date:  2013-04-09       Impact factor: 22.682

9.  Deaths: leading causes for 2009.

Authors:  Melonie Heron
Journal:  Natl Vital Stat Rep       Date:  2012-10-26

10.  Chronic disease management for patients with cirrhosis.

Authors:  Michael L Volk; John D Piette; Amit S Singal; Anna S F Lok
Journal:  Gastroenterology       Date:  2010-05-27       Impact factor: 33.883

View more
  8 in total

1.  The consequences of cirrhosis in America.

Authors:  Syed-Mohammed R Jafri; Stuart C Gordon
Journal:  Dig Dis Sci       Date:  2015-02       Impact factor: 3.199

2.  Early hospital readmission and survival in patients with cirrhosis: A population-based study.

Authors:  Jeffrey M Mah; Yvonne Dewit; Patti Groome; Maya Djerboua; Christopher M Booth; Jennifer A Flemming
Journal:  Can Liver J       Date:  2019-08-27

3.  Glutathione species and metabolomic prints in subjects with liver disease as biological markers for the detection of hepatocellular carcinoma.

Authors:  Juan R Sanabria; Rajan S Kombu; Guo-Fang Zhang; Yana Sandlers; Jizhou Ai; Rafael A Ibarra; Rime Abbas; Kush Goyal; Henri Brunengraber
Journal:  HPB (Oxford)       Date:  2016-10-27       Impact factor: 3.647

4.  The MELD-Plus: A generalizable prediction risk score in cirrhosis.

Authors:  Uri Kartoun; Kathleen E Corey; Tracey G Simon; Hui Zheng; Rahul Aggarwal; Kenney Ng; Stanley Y Shaw
Journal:  PLoS One       Date:  2017-10-25       Impact factor: 3.240

5.  Hospital readmissions in decompensated cirrhotics: Factors pointing toward a prevention strategy.

Authors:  Siamak M Seraj; Emily J Campbell; Sarah K Argyropoulos; Kara Wegermann; Raymond T Chung; James M Richter
Journal:  World J Gastroenterol       Date:  2017-10-07       Impact factor: 5.742

6.  Years of life lost due to diseases of the digestive system in Poland according to socioeconomic factors: a cross-sectional study.

Authors:  Paulina Paciej-Gołębiowska; Małgorzata Pikala; Irena Maniecka-Bryła
Journal:  BMJ Open       Date:  2019-08-27       Impact factor: 2.692

7.  Fontan-associated liver disease and hepatocellular carcinoma in adults.

Authors:  Tomomi Kogiso; Katsutoshi Tokushige
Journal:  Sci Rep       Date:  2020-12-10       Impact factor: 4.379

8.  Biomarkers and sociodemographic factors predicting one-year readmission among liver cirrhosis patients.

Authors:  Jingyi Dai; Jun Zhao; Yingrong Du; Edward B McNeil; Virasakdi Chongsuvivatwong
Journal:  Ther Clin Risk Manag       Date:  2019-08-08       Impact factor: 2.423

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.